SK-OV-3 cells
Catalog #:
C0017008
Shipping advice:
Use only Express Delivery (overnight) for cell line. International shipping rate please contact us for details
| Frozen vial | USD420.0 |
Disease:
Ovarian serous cystadenocarcinoma
Origin:
Derived from the ascitic fluid from a 64 year old caucasian female with an ovarian tumor. Forms moderately well-differentiated adenocarcinoma consistent with ovarian primary cells.
Species:
Homo sapiens, human
Ovary: ascites
Epithelial
Adherent
Hypodiploid to hypotetraploid
Female, Caucasian, 64 years of age
AddexBio-Formulated DMEM (C0003-03) + 10% FBS
Subculture sub-confluent cultures (85%) at 1:2 to 1:6 ratio, using 0.25% (w/v) Trypsin- 0.53 mM EDTA solution. Culture at 5% CO2, 37°C.
Complete growth culture medium supplemented with 7.5% (v/v) DMSO I
Bacteria: Negative
Yeast: Negative
Mycoplasma: Negative
HIV: Negative
Hepatitis B: Negative
HPV: Negative
EBV: Negative
CMV: Negative
Amelogenin: X
CSF1PO: 11
D13S317: 8,11
D16S539: 12
D5S818:11
D7S820: 13,14
THO1:9,9.3
TPOX: 8,11
vWA: 17,18
If use of this culture results in a scientific publication, it should be cited in the publication as: SK-OV-3 (AddexBio C0017008)
Tissue:
Morphology:
Properties:
Cytogenic data:
Patient:
Medium:
Subculture:
Freezing Medium:
Biosafety Level:
Sterility:
Pathogens:
DNA Profile (STR):
Citation Format:
References for SK-OV-3 cells:
1. Morimoto H, Yonehara S, Bonavida B. Overcoming tumor necrosis factor and drug resistance of human tumor cell lines by combination treatment with anti-Fas antibody and drugs or toxins. Cancer Res. 1993 Jun 1;53(11):2591-2596. PMID: 7684321
